Skip to content

AtriCure ATRC Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR
Avanos Medical logo
Avanos MedicalAVNS
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's common stock, shares, outstanding?
AtriCure (ATRC) reported common stock, shares, outstanding of $50.63M in Q1 2026.
How has AtriCure's common stock, shares, outstanding changed year-over-year?
AtriCure's common stock, shares, outstanding increased by 2.3% year-over-year, from $49.49M to $50.63M.
What is the long-term trend for AtriCure's common stock, shares, outstanding?
Over 5 years (2020 to 2025), AtriCure's common stock, shares, outstanding has grown at a 1.9% compound annual growth rate (CAGR), from $45.35M to $49.79M.